HAVANA – Specialists in the Center of Genetic Engineering and Biotechnology (CIGB) have developed a new medicine called Heberferon, to help eliminate the non-melanoma skin tumors.
Heberferon is the synergic combination of Interferon alpha 2b and gamma recombinants.
This product will be of big boon in the country since Cuba suffers from a incidence of skin cancer due to the long exposure of the people to ultraviolet radiation, said Juventud Rebelde, the director of the research project, Iraldo Bello-Rivero.
This medicine allows the reduction of the tumor mass and the remedy of the injuries, as well as a more rapid and long answer than the obtained one with the interferones separately.
Also, it avoids complex surgeries in areas of high frequency of recurrencias like the ears, the nose, the eyelids and the area periocular, as well as its aftermath, it added.
Other benefits of the Heberferon are its curative effect over a distance, so it is injected into an injury and those of the environment reduce its size or are eliminated.
Also it has antiproliferative action, that is to say, it inhibits the vascularity of the tumor and controls the cellular cycle. -BERNAMA